Andreu-Bernabeu, Álvaro
Díaz-Caneja, Covadonga M. http://orcid.org/0000-0001-8538-3175
Costas, Javier
De Hoyos, Lucía http://orcid.org/0000-0001-7252-1591
Stella, Carol
Gurriarán, Xaquín
Alloza, Clara
Fañanás, Lourdes http://orcid.org/0000-0001-6266-7706
Bobes, Julio http://orcid.org/0000-0003-2187-4033
González-Pinto, Ana
Crespo-Facorro, Benedicto
Martorell, Lourdes
Vilella, Elisabet http://orcid.org/0000-0002-1887-5919
Muntané, Gerard
Nacher, Juan
Molto, María Dolores
Aguilar, Eduardo Jesús http://orcid.org/0000-0002-7875-5644
Parellada, Mara
Arango, Celso http://orcid.org/0000-0003-3382-4754
González-Peñas, Javier http://orcid.org/0000-0002-3850-3012
Article History
Received: 18 December 2020
Accepted: 26 November 2021
First Online: 10 January 2022
Competing interests
: C.A has been a consultant to or has received honoraria or grants from Acadia, Angelini, Gedeon Richter, Janssen Cilag, Lundbeck, Minerva, Otsuka, Roche, Sage, Servier, Shire, Schering Plough, Sumitomo Dainippon Pharma, Sunovion, and Takeda. B.C.-F. has received honoraria (advisory board and educational lectures) and travel expenses from Takeda, Menarini, Angelini, Teva, Otsuka, Lundbeck, and Johnson & Johnson. He has also received unrestricted research grants from Lundbeck. Xaquín Gurriarán has received a grant from Fundación Instituto Roche. C.M.D.-C. has received honoraria from AbbVie, Sanofi, and Exeltis. The rest of the authors declare no competing interests.